Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Interferon gamma has long been studied as a critical mediator of tumor immunity. In recent years, the complexity of cellular interactions that take place in the tumor microenvironment has become better appreciated in the context of immunotherapy. While checkpoint inhibitors have dramatically improved remission rates in cancer treatment, IFN-γ and related effectors continue to be identified as strong predictors of treatment success. In this review, we provide an overview of the multiple immunosuppressive barriers that IFN-γ has to overcome to eliminate tumors, and potential avenues for modulating the immune response in favor of tumor rejection. Copyright © 2019 Elsevier Ltd. All rights reserved.


J Daniel Burke, Howard A Young. IFN-γ: A cytokine at the right time, is in the right place. Seminars in immunology. 2019 Jun;43:101280

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 31221552

View Full Text